348 related articles for article (PubMed ID: 10792004)
1. Th1 and Th2 mediate acute graft-versus-host disease, each with distinct end-organ targets.
Nikolic B; Lee S; Bronson RT; Grusby MJ; Sykes M
J Clin Invest; 2000 May; 105(9):1289-98. PubMed ID: 10792004
[TBL] [Abstract][Full Text] [Related]
2. Ligation of OX40 (CD134) regulates graft-versus-host disease (GVHD) and graft rejection in allogeneic bone marrow transplant recipients.
Blazar BR; Sharpe AH; Chen AI; Panoskaltsis-Mortari A; Lees C; Akiba H; Yagita H; Killeen N; Taylor PA
Blood; 2003 May; 101(9):3741-8. PubMed ID: 12521997
[TBL] [Abstract][Full Text] [Related]
3. The susceptibility to experimental myasthenia gravis of STAT6-/- and STAT4-/- BALB/c mice suggests a pathogenic role of Th1 cells.
Wang W; Ostlie NS; Conti-Fine BM; Milani M
J Immunol; 2004 Jan; 172(1):97-103. PubMed ID: 14688314
[TBL] [Abstract][Full Text] [Related]
4. The role of CD154-CD40 versus CD28-B7 costimulatory pathways in regulating allogeneic Th1 and Th2 responses in vivo.
Kishimoto K; Dong VM; Issazadeh S; Fedoseyeva EV; Waaga AM; Yamada A; Sho M; Benichou G; Auchincloss H; Grusby MJ; Khoury SJ; Sayegh MH
J Clin Invest; 2000 Jul; 106(1):63-72. PubMed ID: 10880049
[TBL] [Abstract][Full Text] [Related]
5. Contrasting roles for STAT4 and STAT6 signal transduction pathways in murine renal ischemia-reperfusion injury.
Yokota N; Burne-Taney M; Racusen L; Rabb H
Am J Physiol Renal Physiol; 2003 Aug; 285(2):F319-25. PubMed ID: 12709397
[TBL] [Abstract][Full Text] [Related]
6. Effect of targeted disruption of STAT4 and STAT6 on the induction of experimental autoimmune encephalomyelitis.
Chitnis T; Najafian N; Benou C; Salama AD; Grusby MJ; Sayegh MH; Khoury SJ
J Clin Invest; 2001 Sep; 108(5):739-47. PubMed ID: 11544280
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice.
Murphy WJ; Welniak LA; Taub DD; Wiltrout RH; Taylor PA; Vallera DA; Kopf M; Young H; Longo DL; Blazar BR
J Clin Invest; 1998 Nov; 102(9):1742-8. PubMed ID: 9802888
[TBL] [Abstract][Full Text] [Related]
8. Role of STAT4 and STAT6 signaling in allograft rejection and CTLA4-Ig-mediated tolerance.
Zhou P; Szot GL; Guo Z; Kim O; He G; Wang J; Grusby MJ; Newell KA; Thistlethwaite JR; Bluestone JA; Alegre ML
J Immunol; 2000 Nov; 165(10):5580-7. PubMed ID: 11067913
[TBL] [Abstract][Full Text] [Related]
9. Pretreatment of donors with interleukin-18 attenuates acute graft-versus-host disease via STAT6 and preserves graft-versus-leukemia effects.
Reddy P; Teshima T; Hildebrandt G; Williams DL; Liu C; Cooke KR; Ferrara JL
Blood; 2003 Apr; 101(7):2877-85. PubMed ID: 12433681
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of host NKT cells by synthetic glycolipid regulates acute graft-versus-host disease by inducing Th2 polarization of donor T cells.
Hashimoto D; Asakura S; Miyake S; Yamamura T; Van Kaer L; Liu C; Tanimoto M; Teshima T
J Immunol; 2005 Jan; 174(1):551-6. PubMed ID: 15611282
[TBL] [Abstract][Full Text] [Related]
11. Neonatal tolerance in the absence of Stat4- and Stat6- dependent Th cell differentiation.
Chang HC; Zhang S; Kaplan MH
J Immunol; 2002 Oct; 169(8):4124-8. PubMed ID: 12370340
[TBL] [Abstract][Full Text] [Related]
12. Inducible Costimulator Gene-Transduced Bone Marrow-Derived Mesenchymal Stem Cells Attenuate the Severity of Acute Graft-Versus-Host Disease in Mouse Models.
Yang D; Wang LP; Zhou H; Cheng H; Bao XC; Xu S; Zhang WP; Wang JM
Cell Transplant; 2015; 24(9):1717-31. PubMed ID: 25203502
[TBL] [Abstract][Full Text] [Related]
13. Different competitive capacities of Stat4- and Stat6-deficient CD4+ T cells during lymphophenia-driven proliferation.
Sanchez-Guajardo V; Borghans JA; Marquez ME; Garcia S; Freitas AA
J Immunol; 2005 Feb; 174(3):1178-87. PubMed ID: 15661871
[TBL] [Abstract][Full Text] [Related]
14. Increased susceptibility of Stat4-deficient and enhanced resistance in Stat6-deficient mice to infection with Trypanosoma cruzi.
Tarleton RL; Grusby MJ; Zhang L
J Immunol; 2000 Aug; 165(3):1520-5. PubMed ID: 10903759
[TBL] [Abstract][Full Text] [Related]
15. Targeting of inducible costimulator (ICOS) expressed on alloreactive T cells down-regulates graft-versus-host disease (GVHD) and facilitates engraftment of allogeneic bone marrow (BM).
Taylor PA; Panoskaltsis-Mortari A; Freeman GJ; Sharpe AH; Noelle RJ; Rudensky AY; Mak TW; Serody JS; Blazar BR
Blood; 2005 Apr; 105(8):3372-80. PubMed ID: 15618467
[TBL] [Abstract][Full Text] [Related]
16. Recovery from established graft-vs-host disease achieved by bone marrow transplantation from a third-party allogeneic donor.
Taniguchi Y; Yoshihara S; Hoshida Y; Inoue T; Fujioka T; Ikegame K; Kawakami M; Masuda T; Aozasa K; Kawase I; Ogawa H
Exp Hematol; 2008 Sep; 36(9):1216-25. PubMed ID: 18599183
[TBL] [Abstract][Full Text] [Related]
17. Kinetics and STAT4- or STAT6-mediated regulation of genes involved in lymphocyte polarization to Th1 and Th2 cells.
Lund RJ; Ylikoski EK; Aittokallio T; Nevalainen O; Lahesmaa R
Eur J Immunol; 2003 Apr; 33(4):1105-16. PubMed ID: 12672077
[TBL] [Abstract][Full Text] [Related]
18. Stat4 and Stat6 signaling in hepatic ischemia/reperfusion injury in mice: HO-1 dependence of Stat4 disruption-mediated cytoprotection.
Shen XD; Ke B; Zhai Y; Gao F; Anselmo D; Lassman CR; Busuttil RW; Kupiec-Weglinski JW
Hepatology; 2003 Feb; 37(2):296-303. PubMed ID: 12540779
[TBL] [Abstract][Full Text] [Related]
19. Differential effect of CTLA4Ig on murine graft-versus-host disease (GVHD) development: CTLA4Ig prevents both acute and chronic GVHD development but reverses only chronic GVHD.
Via CS; Rus V; Nguyen P; Linsley P; Gause WC
J Immunol; 1996 Nov; 157(9):4258-67. PubMed ID: 8892665
[TBL] [Abstract][Full Text] [Related]
20. Cutting edge: differential expression of chemokines in Th1 and Th2 cells is dependent on Stat6 but not Stat4.
Zhang S; Lukacs NW; Lawless VA; Kunkel SL; Kaplan MH
J Immunol; 2000 Jul; 165(1):10-4. PubMed ID: 10861028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
